Endometriosis (EMs) is a prevalent, estrogen-dependent gynecological disorder characterized by the ectopic implantation and proliferation of endometrial-like tissue outside the uterine cavity, affecting approximately 10% of reproductive-aged women globally. Despite …
Elagolix and Myfembree are gonadotropin-releasing hormone (GnRH)-pathway therapies used for endometriosis, but their post-marketing safety reporting patterns remain incompletely characterized. Because spontaneous reporting databases are susceptible to reporting bias and …
Background/Objectives: This study evaluates the 1-year follow-up outcomes after minimally invasive nerve-sparing surgery for the complete excision of deep endometriosis (DE), with a specific focus on deep dyspareunia. Cases with …
A drug for endometriosis and breast cancer leaves the PBS - but remains for prostate cancer RUSSH
Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG Contemporary OB/GYN
Brianna Chickenfry breaks down 'nightmare' next steps after emergency surgery: 'F--king sucks' Page Six
Brianna Chickenfry breaks down 'nightmare' next steps after emergency surgery: 'F--king sucks' pagesix.com
Watch: Emma Barnett on her struggles with Endometriosis Metro.co.uk
Blood-based profiling could lead to earlier endometriosis care Contemporary OB/GYN
Emerging signal transduction pathways and the role of bacterial extracellular vesicles linked to the pathogenesis of endometriosis Nature